Summary of project PR002637

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002637. The data can be accessed directly via it's Project DOI: 10.21228/M8SK0W This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR002637
Project DOI:doi: 10.21228/M8SK0W
Project Title:The Ability of Dietary Polyunsaturated Fatty Acids to Protect Against Liver Inflammation and Non-Alcoholic Steatohepatitis (NASH) is Dependent on Gut Microbes
Project Summary:Non-alcoholic steatohepatitis (NASH) is a rapidly expanding form of liver disease associated with increased risk of cardiometabolic pathologies. Several clinical trials have shown that dietary ω3 polyunsaturated fatty acid (PUFA) supplementation, in particular eicosapentaenoic acid (EPA, 20:5,ω3) and docosahexaenoic acid (DHA, 22:6,ω3), improves health outcomes in NASH patients and lowers cardiovascular diseases. It is shown that ω3 PUFAs can suppress hepatic lipogenesis, resolve hepatic inflammation, and lower plasma triglycerides by reducing the production of hepatic very low-density lipoprotein. In parallel, there is emerging evidence that the gut microbiome can powerfully impact NASH via similar mechanisms. Although dietary PUFA supplementation can strongly impact host lipid metabolic pathways in the liver, it is often overlooked that gut microbiota can also synthesize and degrade diverse lipids. Here, we hypothesized that the ability of dietary PUFAs to suppress NASH and cardiometabolic diseases is dependent on microbe-host co-metabolism of lipids. This study provides a comprehensive lipidomic analysis defining unique dietary fatty acid-microbe-host interactions and have uncovered new insights into how meta-organismal metabolism impacts liver diseases and metabolic disorders.
Institute:Cleveland Clinic
Department:Cardiovascular and Metabolic Sciences
Laboratory:Brown Lab
Last Name:Brown
First Name:J. Mark
Address:9500 Euclid Avenue, Cleveland, Ohio, 44196, USA
Email:brownm5@ccf.org
Phone:216 444 8340

Summary of all studies in project PR002637

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST004181 The Ability of Dietary Polyunsaturated Fatty Acids to Protect Against Liver Inflammation and Non-Alcoholic Steatohepatitis (NASH) is Dependent on Gut Microbes Mus musculus Cleveland Clinic MS* 2025-09-28 1 122 Uploaded data (25G)*
  logo